| Oct 15 2026 |
GLOBE and MFN Pricing: Implications for Cross-Border Drug Development and Transactions |
Greenberg Traurig, LLP |
| Oct 15 2026 |
FinCEN Targets $17.5 Billion in Suspected Health Care Fraud |
Ballard Spahr LLP |
| Oct 15 2026 |
CMS Receives Its Exclusion Authority: What Happens Now? |
Epstein Becker & Green, P.C. |
| Oct 15 2026 |
CONGRATULATIONS, YOU’RE A HEALTH COMPANY NOW. |
Troutman Amin, LLP |
| Oct 15 2026 |
This Week in 340B: October 6 – 12, 2026 |
McDermott Will & Schulte LLP |
| Oct 15 2026 |
HazCom’s November 20 Deadline: What Employers Still Have Time to Fix |
Robinson & Cole LLP |
| Oct 15 2026 |
Virginia Expands Non-Compete Restrictions in 2026 |
Polsinelli PC |
| Oct 15 2026 |
Wage + Hour Compliance in Healthcare: Particular Problems, Practical Solutions [Video] |
Jackson Lewis P.C. |
| Oct 14 2026 |
Mental Health Parity Under the Trump Administration: Where DOL Is Headed and What Congress Is Doing About It |
Mintz |
| Oct 14 2026 |
FDA Plans Measures to Mitigate and Prevent Cyclospora Outbreaks |
Keller and Heckman LLP |
| Oct 14 2026 |
When Things Go Wrong: Talking to Your Patient After a Bad Outcome |
Ward and Smith, P.A. |
| Oct 13 2026 |
FDA Releases 2025 CORE-EP Annual Report |
Keller and Heckman LLP |
| Oct 12 2026 |
DOJ Fraud Division Orders Broader, Faster Enforcement |
Bracewell LLP |
| Oct 12 2026 |
GLOBE Model Final Rule Drops — But Will It Work on a Smaller Scale? |
Epstein Becker & Green, P.C. |
| Oct 12 2026 |
Competition Currents | October 2026 |
Greenberg Traurig, LLP |
| Oct 12 2026 |
Arkansas Court of Appeals Confirms Insurers’ Defense Obligation in Opioid Litigation — and Rejects an Arbitration End-Run |
Bradley Arant Boult Cummings LLP |
| Oct 9 2026 |
Florida Medicaid Resumes Enrollment of New DME Providers After Six-Month Moratorium |
Polsinelli PC |
| Oct 9 2026 |
DOJ Corporate Fraud Enforcement Memo: What Health Care Companies Need to Know Now |
Epstein Becker & Green, P.C. |
| Oct 9 2026 |
2026 State Attorneys General Election Report |
Foley & Lardner LLP |
| Oct 9 2026 |
Congressional Action on Health Care Cybersecurity: HISAA is Re-Introduced and the Health Care Cybersecurity and Resiliency Act Moves Forward |
Epstein Becker & Green, P.C. |
| Oct 9 2026 |
Assisted Living Facilities in Florida, New Memory Care Rules |
Shumaker |
| Oct 8 2026 |
Attorneys General of Three States File Two Sweeping Lawsuits Targeting Telehealth Abortion Providers and State Shield Laws |
Epstein Becker & Green, P.C. |
| Oct 8 2026 |
New Biosimilar Legislation Addresses Inflation Reduction Act Delay Provision |
Polsinelli PC |
| Oct 8 2026 |
The Medical Device Launch Playbook: Patents, FDA, Reimbursement and Strategic Timing |
Polsinelli PC |
| Oct 8 2026 |
RFI Seeks Input on Medicare Part D’s Pharmacy Contract Standards |
Epstein Becker & Green, P.C. |
| Oct 8 2026 |
Washington, D.C. Bans Medical Debt from Credit Reports |
Ballard Spahr LLP |
| Oct 8 2026 |
Diagnosing Health Care - Episode 95 Why Hospitals Should Start Now on Off-Campus NPIs and Attestations [Podcast] |
Epstein Becker & Green, P.C. |
| Oct 8 2026 |
Five Ways Health Systems are Responding to the Medicare Supplemental Phase Out |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 7 2026 |
Proposed H.R. 10336 Would Balance Innovation, Access to Dietary Supplements—Yet Change the Definition |
Epstein Becker & Green, P.C. |
| Oct 7 2026 |
DOJ Fraud Division Issues Corporate Enforcement Directive Establishing Framework for Corporate Fraud Investigations |
Barnes & Thornburg LLP |
| Oct 7 2026 |
Beyond Animal Testing: FDA's 2026 Framework for Fit-for-Purpose NAMs |
Foley & Lardner LLP |
| Oct 7 2026 |
340B Rebate Pilot — The Clock Starts Now |
Mintz |
| Oct 7 2026 |
Federal Trade Commission Sends Price Transparency Warning Letters to 24 Health Systems |
Epstein Becker & Green, P.C. |
| Oct 6 2026 |
And/Or Else- “And/Or” Renders a Communicable Disease Exclusion Ambiguous |
Hunton Andrews Kurth |
| Oct 6 2026 |
HKS Architects Liable for Defective Structural Designs on Hospital Project |
Bradley Arant Boult Cummings LLP |
